Trial reportBMC palliative care2025
Efficacy of the "PalliActive Caregivers" intervention for caregivers of patients with cancer in palliative care.
Trial report in BMC palliative care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT12345678, which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundFamily caregivers of patients in palliative care in low- and middle-income countries need intervention. This study aimed to determine the efficacy of the nursing program “PalliActive Caregivers,” on increasing role adoption, the perception of social support, and the quality of life of family caregivers of cancer patients in palliative care in a healthcare institution in Medellín, Colombia.
methodA controlled randomized trial was conducted from June through December 2022. The study included adult caregivers for patients with cancer in palliative care. A 1:1 randomization method was used. The experimental arm received two individual sessions with an educational booklet and a mobile application for support (approximately 15 and 75 min). The control arm received two hours of group education about symptom management. Sociodemographic variables, as well as quality of life, role adoption, and perception of social support, were measured before the intervention and at two- and four-weeks post-intervention.
resultsOne hundred fifteen family caregivers were randomized (experimental, n = 58; control, n = 57). At two weeks post-intervention, caregivers in the experimental group reported significantly greater role adoption (98.55 vs. 87.28, p < 0.01), better perceived social support (83.83 vs. 72.96, p < 0.01), and better quality of life in three of its dimensions (caregiver status, caregiver perspective, relationships) than did the controls. The efficacy of the intervention was evident at the first post-measurement; however, significantly higher scores were observed only at four weeks post-intervention on role adoption (103.79 vs. 87.36; p < 0.01), and for three dimensions of quality of life.
conclusionsCompared with conventional care, the PalliActive Caregiver intervention significantly improved caregiver role adoption and the perception of social support among caregivers of cancer patients in palliative care. It is recommended that future studies evaluate the effect of the intervention on patient outcomes.
trial registrationThis trial is registered in ClinicalTrials.gov “Uncertainty in Illness in Palliative Care: an Intervention for Family Caregivers” with registry number NCT12345678, registered on 2018-05-14.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.